High-throughput time-resolved FRET reveals Akt/PKB activation as a poor prognostic marker in breast cancer.
Veeriah S, Leboucher P, de Naurois J, Jethwa N, Nye E, Bunting T, Stone R, Stamp G, Calleja V, Jeffrey SS, Parker PJ, Larijani B.
Veeriah S, et al. Among authors: larijani b.
Cancer Res. 2014 Sep 15;74(18):4983-95. doi: 10.1158/0008-5472.CAN-13-3382. Epub 2014 Jun 26.
Cancer Res. 2014.
PMID: 24970478